From Jan. 1 2013 to Dec. 31, 2022, the company allegedly encouraged physicians to order excessive and unnecessary urine drug tests through the promotion of “custom profiles.” These profiles, which were essentially standing orders, led physicians to order a large number of tests, according to an October 2 news release from the Department of Justice.
Precision also allegedly provided physicians with free urine drug test cups on the condition that the specimens be returned to Precision for additional testing.
As part of the settlement, Precision has also entered into a five-year corporate integrity agreement with the Department of Health and Human Services
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.